Antares Pharma, Inc. (ATRS) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

ProductRoyaltyLicensing And Development Revenue
08M15M22M30M38M45M52M60MQ1 2021Q2 2021Q3 2021Q4 2021Q1 2022

Revenue by Geography

UNITED STATESEurope
08M15M22M30M38M45M52M60MQ1 2021Q2 2021Q3 2021Q4 2021Q1 2022

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
025M50M75M100M125M150M175M200MQ1 2021Q2 2021Q3 2021Q4 2021Q1 2022

Margin (%)

Gross MarginOperating MarginNet Income Margin
03875112150188225262300Q1 2021Q2 2021Q3 2021Q4 2021Q1 2022

Operating Expenses

Research And Development ExpensesOther Expenses
04M8M11M15M19M22M26M30MQ1 2021Q2 2021Q3 2021Q4 2021Q1 2022

EBITDA

EBITDA
-3M5M13M21M28M36M44M52M60MQ1 2021Q2 2021Q3 2021Q4 2021Q1 2022

EPS

EPSEPS Diluted
000001111Q1 2021Q2 2021Q3 2021Q4 2021Q1 2022

Revenue Variation (%)

Revenue Variation
-20-16-13-9-6-2259Q1 2021Q2 2021Q3 2021Q4 2021Q1 2022

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
02505007501K1K2K2K2KQ1 2021Q2 2021Q3 2021Q4 2021Q1 2022

Revenue YoY Variation (%)

Revenue YoY Variation
-2411182430374450Q1 2021Q2 2021Q3 2021Q4 2021Q1 2022

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
0100200300400500600700800Q1 2021Q2 2021Q3 2021Q4 2021Q1 2022

Price-to-Earning Ratio

P/E Ratio
-90-71-52-34-154224160Q1 2021Q2 2021Q3 2021Q4 2021Q1 2022

Income Breakdown

Operating IncomeTotal Other Income Expenses NetNet Income
011M22M34M45M56M68M79M90MQ1 2021Q2 2021Q3 2021Q4 2021Q1 2022

Per Share Metrics

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
000001111Q1 2021Q2 2021Q3 2021Q4 2021Q1 2022

Expense Ratios

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
000001111Q1 2021Q2 2021Q3 2021Q4 2021Q1 2022
💰 Cash Flow Statement

Operating Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
06M12M19M25M31M38M44M50MQ1 2021Q2 2021Q3 2021Q4 2021Q1 2022

Free Cash Flow

Cash At End Of Period
010M20M30M40M50M60M70M80MQ1 2021Q2 2021Q3 2021Q4 2021Q1 2022

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
04M8M11M15M19M22M26M30MQ1 2021Q2 2021Q3 2021Q4 2021Q1 2022
🏦 Balance Sheet
📈 Key Metrics